SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001082554-20-000019
Filing Date
2020-10-28
Accepted
2020-10-28 06:21:47
Documents
15
Period of Report
2020-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K uthr-20201028.htm   iXBRL 8-K 46568
2 EX-99.1 uthrq32020-exx991.htm EX-99.1 266911
  Complete submission text file 0001082554-20-000019.txt   479150

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20201028.xsd EX-101.SCH 2458
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20201028_cal.xml EX-101.CAL 744
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20201028_def.xml EX-101.DEF 1689
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20201028_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20201028_pre.xml EX-101.PRE 12680
8 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20201028_htm.xml XML 10794
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 201266045
SIC: 2834 Pharmaceutical Preparations